SCD and cancer: The Δ9‐desaturase SCD1, which introduces a single double bond between the 9th and 10th carbons from the fatty acid carboxylate terminus of long‐chain saturated acyl‐CoA has been explored as a therapeutic target in a range of metabolic diseases, skin disorders and cancers.12